Bucharest recorded a 20% decline in office leasing, to 339,000 sqm, in 2024, compared to the previous year, although it remained above the five-year average, according to a Colliers report.
Evo Properties, the owner of London & Oslo office buildings in Western Bucharest, has reached a 50% lease rate this year and aims to reach an occupancy rate of 85% by the end of 2025. At the same time, it continues to transform the project into a mixed-use hub that will include a premium hotel.
Meta Estate Trust has invested in a plot of land near Victoriei Square in central Bucharest, where it plans to develop a building that will be leased to a chain of private medical clinics.
In this mandate, Cushman & Wakefield Echinox is focused on creating the right mix of tenants, responding to the needs of the customers in the area.
CTPark Deva enjoys an ideal geographical location in Transylvania, in the heart of Romania, making it perfect for central distribution centers and manufacturing activities.
The lease renewal is one of the most significant transactions this year, both in the Cluj-Napoca market and in the office market overall.
Very few projects in Bucharest are expected to be delivered in the next two years: only 15,500 sqm in 2024 and 8,000 sqm in 2025.
The study reveals that 83% of Romanians have a plan for their upcoming vacation season. Only 6% do not intend to go on holiday, while 12% have yet to finalize their arrangements.
Travel tech company FlixBus is adding new international coach connections from Romania to Greece and bolstering existing routes to Bulgaria.
EDP, through its subsidiary EDP Renewables, has opened its largest solar park in Romania, located in Albina, taking its total solar and wind capacities in the country to 570 MW.
Dan Air, a private Romanian airline, inaugurated its regular flight service between Bucharest and Damascus on June 15.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).